Have a question or want to speak with a team member?
Stay updated on our progress in changing the landscape of ovarian cancer treatment options and outcomes.
Dec 16, 2022
Clinical Trial: Targeting the targets – investigating an innovative chemotherapy alternative
Two funded clinical trials, though different in their approach and focus, share a dedication to exploring innovative treatment pathways and a made-in-Canada pedigree.
Nov 29, 2022
Research knows no bounds
Ovarian Cancer Canada takes a multi-pronged approach to ensure that all types of the disease, even the rarest ones, are prioritized to ensure that everyone benefits from the best available science as quickly as possible.
Jun 17, 2022
Prize awarded to researcher whose ovarian cancer vaccines are in preclinical studies funded by Ovarian Cancer Canada
Qingchuan Zhao’s research awarded the 2022 Anita Unruh Prize from Ovarian Cancer Canada
Dec 7, 2021
Ovarian Cancer Canada and the Cancer Research Society invest $2.25 million
Ovarian Cancer Canada and the Cancer Research Society invest $2.25 million in ovarian cancer research: Funding for 10 new projects just announced
Aug 17, 2021
Harnessing the power of vaccines to treat ovarian cancer
Most of us have recently heard a great deal about how vaccines help protect against the serious effects of COVID-19. But did you know that vaccines can also be used to treat disease?
Jun 15, 2021
Enabling research on rare forms of ovarian cancer
Dr. Mark Carey is developing scientific models to advance research on low-grade serous cancer, a rare form of the disease.
Apr 6, 2021
IRICoR and Ovarian Cancer Canada announce $2.3M
IRICoR and Ovarian Cancer Canada announce $2.3M for development of new treatments for ovarian cancer
Mar 30, 2021
$1.35 million for ovarian cancer research
The Cancer Research Society and Ovarian Cancer Canada are proud to jointly launch a competition to fund some of Canada’s most promising research projects focused on ovarian cancer. The competition will award up to 6 grants, each totaling $225,000 over a two-year period.
Feb 23, 2021
The benefits of 3D models in ovarian cancer research
These will enable scientists to test new treatments, leading to new clinical trials, and ultimately improved outcomes for women with this disease.